Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease)

NCT07509749 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

GVHD, Acute
Stem Cell Transplant Complications

Interventions

DRUG: Ruxolitinib and Methylprednisolone
DRUG: Methylprednisolone

Sponsor

Daihong Liu